The University of Alabama, Birmingham recently renewed its translational research facility, the Comprehensive Cancer Center/ Wallace Tumor Institute, which is home to a number of state-of-the art research laboratories for leading cancer diagnostic and treatment research in Alabama.
Living 17 years in a Dadaab refugee camp after fleeing Somalia, Africa, Hussein Issak Magale with his family came to the United States with a resettlement opportunity in 2009. After starting off at the University of Arizona in April 2010, Magale has worked in the Orthopaedic Research Lab and participated in an international research program in Kenya, Africa, which is funded by the National Institutes of Health and administrated by the University of Alabama. He will graduate in this May 2014 with a Bachelor of Science in Molecular and Cellular Biology.
The University of Alabama at Birmingham recently received a $4.6 million life science research funding grant from the NIH for the school’s Center for Clinical and Translational Science. Dr. Robert Kimberly is listed as the project leader. According to the University of Alabama, Dr. Kimberly is Senior Associate Dean for Research and Director of the University of Alabama at Birmingham Arthritis and Musculoskeletal Center (AMC). He is also a rheumatologist and immunologist whose research interests include autoimmune disease, systemic lupus erythematosus, systemic vasculitis and rheumatoid arthritis. The NIH RePORTER provides more information on the center receiving the latest $4.6 million in life science funding.
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB
Iron is the most common chemical element found on earth, and it plays a key role in the biochemical processes of almost all organisms. Though iron is an important building block of life, it is also attributed to causing cellular damage when it is released into its free catalytic form. Researchers at the University of Alabama at Birmingham recently published a report in the Journal of Clinical Investigation which sought to help understand the relationship between the protein ferritin and kidney damage caused by this free iron. This study set a foundation for future research into potential treatments to prevent acute kidney injury.
Researchers at the University of Alabama at Birmingham, led by Donald Buchsbaum, PhD, received a $2.2 million grant from the NIH this year to study pancreatic cancer. According to the University of Alabama website, Dr. Buchsbaum is quoted as saying of his research goals: "My interests are focused on the use of monoclonal antibodies that bind to the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors for cancer therapy in combination with chemotherapy agents and radiation.” Dr. Buchsbaum and his research team began receiving funding for their studies of pancreatic cancer six years ago, though funding was limited at that time. The NIH RePORTER sheds light on the project that has received $2.2 million from the NIH this year in the proposal’s abstract:
Researchers at the University of Alabama, Birmingham Comprehensive Cancer Center received a $5.1 million support grant from the NIH this year. The abstract for the grant on NIH RePORTER says of the Comprehensive Cancer Center:
Science researchers at the University of Alabama at Birmingham recently received a $3 million grant that will be distributed over five years to join the Women’s Interagency HIV study (WIHS). Michael Saag, M.D. is the study’s principal investigator, and Mirjam-Collete Kempf, Ph.D., M.P.H. is the co-principal investigator. The researchers will begin recruiting women for the study this coming October.
The National Eye Institute, an NIH agency dedicated to vision research, recently announced the winners of their Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation, or the Audacious Goals Challenge for short. The competition was open to professionals and members of the public and called upon them to think big and bold about vision research goals for the next decades. The prize money was nominal ($3,000) but included an invitation and travel money to attend and present their ideas at the NEI Audacious Goals Development Meeting in Maryland later this month. The real prize, of course, was the opportunity to help set research and funding goals for the next 10-12 years. Of the 500 or so proposals submitted, 10 visionaries were selected as winners.
Tags: University of Michigan, 2014, CA, Harvard University, Midwest, 2013, Northeast, university of utah, Washington University, Missouri, WashU, UUtah, St. Louis Bioresearch Product Faire Event, Oregon Health and Science University, Northwest, crowdsourcing, Vision Sciences Research, National Eye Institute (NEI), Blindness Rehabilitation, Southwest, University of Alabama, Southern, UT, Ann Arbor, Boston, BioResearch Product Faire Event, Funding, MI, MA, NIH, Harvard, OR, Salt Lake City, Birmingham, AL, UCSB, Santa Barbara, OHSU, Portland, UMich, UC Santa Barbara, Rehabilitation
The University of Alabama is an unexpected standout in the science research marketplace. This campus ranks among the top in the nation, flanking closely with the top NIH funded universities, and yet there is surprisingly little sales rep traffic on campus.